Literature DB >> 27230945

The expression of tenascin-C and tenascin-W in human ossicles.

Richard P Tucker1, Cathryn A Peterson2, Ismail Hendaoui3, Sandrine Bichet3, Ruth Chiquet-Ehrismann3,4.   

Abstract

The ossicles of the middle ear (the malleus, incus and stapes) transmit forces resulting from vibrations of the tympanic membrane to the cochlea where they are coded as sound. Hearing loss can result from diseases such as rheumatoid arthritis (RA) that affect the joints between the ossicles or degenerative processes like otosclerosis that lead to ankylosis of the footplate of the stapes in the oval window of the cochlea. In this study, immunohistochemistry was used to determine if the extracellular matrix glycoproteins tenascin-C or tenascin-W are expressed in the incudomalleolar and incudostapedial joints of ossicles dissected from human cadavers. Tenascin-C, which is expressed during inflammatory conditions including RA, was seen in the articular cartilage of the incudomalleolar joints and the head of the stapes. Tenascin-W, in contrast, was enriched in the annular ligament that anchors the footplate of the stapes into the oval window of the cochlea.
© 2016 Anatomical Society.

Entities:  

Keywords:  arthritis; extracellular matrix; hearing loss; ossicle; tenascin

Mesh:

Substances:

Year:  2016        PMID: 27230945      PMCID: PMC4974554          DOI: 10.1111/joa.12496

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  27 in total

1.  Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro.

Authors:  Caroline V Meloty-Kapella; Martin Degen; Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Dev Dyn       Date:  2006-06       Impact factor: 3.780

2.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 3.  Tenascin-W: an extracellular matrix protein associated with osteogenesis and cancer.

Authors:  Enrico Martina; Ruth Chiquet-Ehrismann; Florence Brellier
Journal:  Int J Biochem Cell Biol       Date:  2010-06-09       Impact factor: 5.085

4.  Hearing loss in rheumatoid arthritis.

Authors:  V V Raut; J Cullen; G Cathers
Journal:  J Otolaryngol       Date:  2001-10

5.  Hearing loss and middle ear involvement in rheumatoid arthritis.

Authors:  Müge Ozcan; M Fatih Karakuş; Osman Hakan Gündüz; Umit Tuncel; Hasan Sahin
Journal:  Rheumatol Int       Date:  2002-05       Impact factor: 2.631

6.  Hearing difficulties are common in patients with rheumatoid arthritis.

Authors:  Louisa Murdin; Sanjeev Patel; Josephine Walmsley; Lam Hoe Yeoh
Journal:  Clin Rheumatol       Date:  2007-12-11       Impact factor: 2.980

7.  Anatomy of the distal incus in humans.

Authors:  Wade Chien; Clarinda Northrop; Stephen Levine; Ben Z Pilch; William T Peake; John J Rosowski; Saumil N Merchant
Journal:  J Assoc Res Otolaryngol       Date:  2009-08-15

8.  Tenascin-C in serum: a questionable tumor marker.

Authors:  S Schenk; J Muser; G Vollmer; R Chiquet-Ehrismann
Journal:  Int J Cancer       Date:  1995-05-16       Impact factor: 7.396

Review 9.  Tenascins in stem cell niches.

Authors:  Ruth Chiquet-Ehrismann; Gertraud Orend; Matthias Chiquet; Richard P Tucker; Kim S Midwood
Journal:  Matrix Biol       Date:  2014-01-25       Impact factor: 11.583

Review 10.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

View more
  1 in total

1.  Tenascin-W: Discovery, Evolution, and Future Prospects.

Authors:  Martin Degen; Arnaud Scherberich; Richard P Tucker
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.